Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09AMZ
|
||||
Former ID |
DAP000597
|
||||
Drug Name |
Enprofylline
|
||||
Synonyms |
Enprofilina; Enprofyllinum; Nilyph; Oxeze; P 5679; D-4028; Enprofilina [INN-Spanish]; Enprofylline [USAN:INN]; Enprofyllinum [INN-Latin]; Enprofylline (USAN/INN); 3,7-Dihydro-3-propyl-1H-purine-2,6-dione; 3-Propyl-3,7-dihydro-purine-2,6-dione; 3-Propylxanthine; 3-n-Propylxanthine; 3-propyl-3,7-dihydro-1H-purine-2,6-dione; 3-propyl-7H-purine-2,6-dione
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Asthma [ICD10:J45] | Approved | [537725] | ||
Therapeutic Class |
Antiinflammatory Agents
|
||||
Structure |
Download2D MOL |
||||
Formula |
C8H10N4O2
|
||||
Canonical SMILES |
CCCN1C2=C(C(=O)NC1=O)NC=N2
|
||||
InChI |
1S/C8H10N4O2/c1-2-3-12-6-5(9-4-10-6)7(13)11-8(12)14/h4H,2-3H2,1H3,(H,9,10)(H,11,13,14)
|
||||
InChIKey |
SIQPXVQCUCHWDI-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 41078-02-8
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
855784, 4285594, 8151233, 11111643, 12012874, 14772979, 15219898, 17398000, 17405468, 24277687, 26751510, 29220879, 46505790, 47365405, 47736695, 47810964, 48035338, 48110660, 50028023, 50100320, 50104067, 50104068, 53778016, 57320977, 72794359, 78817644, 85088984, 85209069, 85231189, 85331227, 90341781, 92304175, 103131576, 103188003, 103915958, 104171214, 104298395, 117600223, 121361566, 124750090, 124800765, 124881140, 124881141, 124881142, 124881143, 129241696, 132554404, 134222975, 134337888, 134338586
|
||||
Target and Pathway | |||||
Target(s) | CAMP-specific 3',5'-cyclic phosphodiesterase 4A | Target Info | Inhibitor | [537725] | |
WikiPathways | G Protein Signaling Pathways | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.